Inpatient pharmacy experience with an audit for a risk evaluation and mitigation strategy for riociguat.

Smith, Zachary R; Makowski, Charles T; MacDonald, Nancy C

Smith, Zachary R; Makowski, Charles T; MacDonald, Nancy C.

Affiliation

Smith ZR; Department of PharmacyHenry Ford HospitalDetroit, MIzsmith1@hfhs.org.
Makowski CT; Department of PharmacyHenry Ford HospitalDetroit, MI.
MacDonald NC; Department of PharmacyHenry Ford HospitalDetroit, MI.

Am J Health Syst Pharm ; 74(21): 1762-1763, 2017 11 01.

Article in En | MEDLINE | ID: mdl-29070497

Subject(s)

Medical Audit; Pyrazoles/administration & dosage; Pyrazoles/therapeutic use; Pyrimidines/administration & dosage; Pyrimidines/therapeutic use; Risk Evaluation and Mitigation; Humans; Inpatients; Pharmacy Service, Hospital/organization & administration; United States; United States Food and Drug Administration

Key words

audit; inpatient pharmacy; riociguat; risk evaluation and mitigation strategy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyrimidines / Risk Evaluation and Mitigation / Medical Audit Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am J Health Syst Pharm Journal subject: FARMACIA / HOSPITAIS Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google